BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute; FORTIFY trial to assess CERAMENT G as part of the surgical repair of severe tibial fractures

Press/Media: Press / Media

PeriodMay 22 2017

Media coverage

3

Media coverage

  • TitleBONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute; FORTIFY trial to assess CERAMENT G as part of the surgical repair of severe tibial fractures
    Media name/outletPR Newswire
    CountryUnited States
    Date5/22/17
    PersonsRavi Karia
  • TitleBONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute; FORTIFY trial to assess CERAMENT G as part of the surgical repair of severe tibial fractures
    Media name/outletPR Newswire European (Top News)
    CountryUnited Kingdom
    Date5/22/17
    PersonsRavi Karia
  • TitleBONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute; FORTIFY trial to assess CERAMENT G as part of the surgical repair of severe tibial fractures
    Media name/outletPR Newswire European (Top News)
    CountryUnited Kingdom
    Date5/22/17
    PersonsRavi Karia